LIFE SCIENCES ANALYTICS MARKET ANALYSIS

Regional Analysis

Global Life Sciences Analytics Market: Regional Insights

Based on geography, the global life sciences analytics market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period due to the rising incidence of non-communicable diseases. The main types of NCD are heart diseases, cancers, diabetes, and chronic respiratory diseases. Analytics helps understand the components needed for new drug discovery or drug development. For instance, according to the U.S. Centers for Disease Control and Prevention (CDC), chronic diseases, such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.

Asia Pacific is also expected to witness significant growth in the global life sciences analytics market due to the increasing prevalence of chronic diseases and growing geriatric population in this region. Life science organizations and market players are using analytical solutions in advanced revenue cycle management and population health management programs. According to the National Center for Biotechnology Information, more than 21% of the elderly in India reportedly have at least one chronic disease.

Figure 1. Global Life Sciences Analytics Market Share (%), by Region, 2021

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa